Literature DB >> 12441147

Derivatization of F2-isoprostanes with 1-pyrenyldiazomethane and their subsequent determination by fluorescence high-performance liquid chromatography.

Vladimir B Ritov1, David E Kelley, Valerian E Kagan.   

Abstract

F(2)-isoprostanes are produced during free radical oxidation of cell phospholipids and are considered reliable biomarkers of oxidative stress. Currently, mass spectroscopy is the method of choice to detect F(2)-isoprostanes. However, due to numerous isomeric forms, analysis of F(2)-isoprostanes using MS detectors requires preliminary chromatographic separation. The current study was undertaken to develop a method of HPLC separation and quantification of different isomers of prostaglandin F(2alpha), including 8-iso-PGF(2alpha), following derivatization with 1-pyrenyldiazomethane (PDAM) to a highly fluorescent 1-pyrenylmethyl ester. HPLC separation and quantification of 1-pyrenylmethyl esters of PGF(2alpha) isomers at picogram level are complicated by numerous interfering products of the degradation of 1-pyrenyldiazomethane. A procedure of derivatization and purification was developed to reduce these interfering contaminants. The procedure of derivatization includes sorption of PGF(2alpha) isomers from solution in a hexane:ethyl acetate mixture (10:1) on a cellulose support prepared in the form of small (4 x 4mm) filter paper squares. Bound PGF(2alpha) isomers are derivatized by 1-pyrenyldiazomethane dissolved in the same hexane:ethyl acetate mixture. During subsequent washing of the cellulose squares by the hexane:ethyl acetate mixture (10:1), fluorescent derivatives of PGF(2alpha) remain bound to cellulose while a significant portion of the contaminants are washed out. The 1-pyrenylmethyl esters of PGF(2alpha) can be quantitatively extracted from cellulose by an ethyl acetate:methanol (1:1) mixture. The next step in eliminating interference is a solid-phase extraction on silica cartridges using ethyl acetate for application of the sample and an ethyl acetate:methanol (1:1) mixture for elution. Final purification is achieved by normal-phase HPLC with wet ethyl acetate as the mobile phase. This chromatographic method displays remarkable resolution in the separation of different PGF(2alpha) isomers and can be used not only for sample purification but also for pre-MS separation. The purified 1-pyrenylmethyl esters of PGF(2alpha) were quantitatively analyzed by reverse-phase HPLC with fluorescent detection, with a detection limit of 5-10 pg. Copyright 2002 Elsevier Science (USA)

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12441147     DOI: 10.1016/s0003-2697(02)00392-5

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  4 in total

1.  Simultaneous HPLC-MS-MS quantification of 8-iso-PGF(2alpha) and 8,12-iso-iPF(2alpha) in CSF and brain tissue samples with on-line cleanup.

Authors:  Magdalena Korecka; Christopher M Clark; Virginia M-Y Lee; John Q Trojanowski; Leslie M Shaw
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2010-07-01       Impact factor: 3.205

2.  Oxidative stress and cellular stress response in diabetic nephropathy.

Authors:  Vittorio Calabrese; Cesare Mancuso; Maria Sapienza; Eduardo Puleo; Stella Calafato; Carolin Cornelius; Manuela Finocchiaro; Andrea Mangiameli; Maurizio Di Mauro; Anna Maria Giuffrida Stella; Pietro Castellino
Journal:  Cell Stress Chaperones       Date:  2007       Impact factor: 3.667

Review 3.  Lipoxidation in cardiovascular diseases.

Authors:  Erica Gianazza; Maura Brioschi; Alma Martinez Fernandez; Cristina Banfi
Journal:  Redox Biol       Date:  2019-02-25       Impact factor: 11.799

4.  Cellular stress response, redox status, and vitagenes in glaucoma: a systemic oxidant disorder linked to Alzheimer's disease.

Authors:  Angela Trovato Salinaro; Carolin Cornelius; Guido Koverech; Angela Koverech; Maria Scuto; Francesca Lodato; Vincenzo Fronte; Vera Muccilli; Michele Reibaldi; Antonio Longo; Maurizio G Uva; Vittorio Calabrese
Journal:  Front Pharmacol       Date:  2014-06-06       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.